Physician

Tinyee Tsai Chang, MD

According to 2025 Medicare claims, Tinyee Chang, MD (NPI: 1386861409) practices dermatology in the Redding, CA market, with the plurality of this provider's patient population coming from Shasta, CA. This provider's primary affiliated billing organization is TLC DERMATOLOGY MEDICAL CENTER, INC. (NPI: 1174916506; TIN: 471400357) and primary practice location at 96001-3653.

Chang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,491 traditional Medicare patients, billed 23,615 HCPCS/CPT codes, and received $1,874,223 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 2,944 prescription claims across 1,028 beneficiaries totaling $2,888,406 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 162 records totaling $2,855. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $801,755 to $1,874,223. Similarly, Part D prescription costs have moved sharply higher in recent years, from $205,652 to $2,888,406. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.0M$2.0M2015 Medicare payment: $801,755 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $960,995 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $965,932 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,262,473 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,019,885 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,738,394 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,410,571 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,366,822 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,511,339 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,874,223 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,76512,611$801,755
20162,04616,485$960,995
20172,32717,306$965,932
20182,46219,020$1,262,473
20192,46521,734$2,019,885
20202,37420,195$1,738,394
20212,46716,990$1,410,571
20222,50517,768$1,366,822
20232,39418,922$1,511,339
20242,49123,615$1,874,223

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.4M$2.9M2015 Drug cost: $205,652 (USD; Tot_Drug_Cst)2016 Drug cost: $237,626 (USD; Tot_Drug_Cst)2017 Drug cost: $375,961 (USD; Tot_Drug_Cst)2018 Drug cost: $494,609 (USD; Tot_Drug_Cst)2019 Drug cost: $794,876 (USD; Tot_Drug_Cst)2020 Drug cost: $1,010,758 (USD; Tot_Drug_Cst)2021 Drug cost: $1,444,342 (USD; Tot_Drug_Cst)2022 Drug cost: $1,717,041 (USD; Tot_Drug_Cst)2023 Drug cost: $2,621,934 (USD; Tot_Drug_Cst)2024 Drug cost: $2,888,406 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154221,071$205,652
20164321,127$237,626
20175601,384$375,961
20185951,653$494,609
20195951,620$794,876
20206922,041$1,010,758
20217182,067$1,444,342
20227522,153$1,717,041
20238352,308$2,621,934
20241,0282,944$2,888,406

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17004Destruction of precancer skin growth, 15 or more growths1,6703,526$133
17110Destruction of skin growth, 1-14 growths1,5352,438$94
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more1,4132,538$42
17000Destruction of precancer skin growth, 1 growth1,4992,416$40
17003Destruction of precancer skin growth, 2-14 growths1,4552,289$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab1474,102$548,762
Skyrizi PenRisankizumab-Rzaa272,267$538,145
Dupixent SyringeDupilumab1072,996$392,024
Taltz AutoinjectorIxekizumab471,484$360,573
Humira(Cf) PenAdalimumab401,120$342,613

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.162$2,855ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Tinyee Tsai Chang, MD?

Tedicare shows public-source Medicare data for Tinyee Tsai Chang, MD (NPI 1386861409), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tinyee Tsai Chang, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tinyee Tsai Chang, MD?

Tinyee Tsai Chang, MD is linked to TLC DERMATOLOGY MEDICAL CENTER, INC. (billing NPI 1174916506) in the available physician profile data.

Does Tinyee Tsai Chang, MD have Open Payments data?

Tinyee Tsai Chang, MD has 162 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.